Our mission is to improve patient care by providing clinicians with life-saving cardiac diagnostic products. With a focus on accuracy and timeliness, we empower physicians to deliver superior care through complete control of the diagnostic process.
We are committed to our core values, including customer satisfaction, accountability, integrity, respect, trust, ethics, and excellence, ensuring optimized diagnosis. Join us in transforming cardiac healthcare for the better.
To develop accurate, timely and life-saving ECG diagnostics for all.
Cardiac Insight strives to improve the quality of patient care with innovative cardiac diagnostic products that help clinicians save lives.
Empowering physicians to provide superior care by fully controlling the optimized diagnostic process.
Our mission is to improve patient care by providing clinicians with life-saving cardiac diagnostic products. With a focus on accuracy and timeliness, we empower physicians to deliver superior care through complete control of the diagnostic process.
We are committed to our core values, including customer satisfaction, accountability, integrity, respect, trust, ethics, and excellence, ensuring the optimized diagnosis. Join us in transforming cardiac healthcare for the better.
To develop accurate, timely and life-saving ECG diagnostics for all.
Cardiac Insight strives to improve the quality of patient care with innovative cardiac diagnostic products that help clinicians save lives.
Empowering physicians to provide superior care by fully controlling the optimized diagnostic process.
Min Kim serves as the CEO of both Cardiac Insight and Dreamtech, a parent company of Cardiac Insight.
Since joining Dreamtech in 2014, Mr. Kim has orchestrated multiple international strategic alliances and M&A deals, bolstering the company’s competitiveness in medical device development and manufacturing. In early 2019, he led the company to a successful IPO on KOSPI, achieving a remarkable market capitalization of $600 million.
Prior to his tenure at Dreamtech, Mr. Kim held pivotal roles at renowned investment banking firms, including Samsung Securities and Lehman Brothers, where he significantly contributed to M&A and fundraising transactions surpassing $5 billion.
He holds an MBA from the Wharton School of the University of Pennsylvania and a B.S. in Finance from the University of Southern California.
With a Ph.D. in Geophysics and Seismology from Caltech, Dr. Hadley co-founded Sierra Geophysics during his graduate years, which later transitioned into a successful software company for the oil and gas exploration industry.
He went on to lead several companies in the diagnostic cardiology field, including Quinton Cardiology, where he rebuilt the engineering team and developed various products.
His collaborative work with Dr. Victor Froelicher, a professor of medicine and consultant in Sports Cardiology at Stanford Health Care, resulted in important research on ECG analysis and the development of the “Stanford Criteria.” Dr. Hadley’s efforts culminated in creating Cardea 20/20, utilizing the “International Consensus Criteria” to make ECG screening economical and valuable.
Before joining Cardiac Insight, Roy Kim was a Senior Vice President & Area Banking Manager at Hanmi Bank in Los Angeles, California. He was responsible for managing a commercial portfolio with over $500 million in assets and liabilities of over $1.2 billion.
He was also accountable for overall team leadership and financial management, including overseeing credit portfolios and client deposit relationships for the past 26 years.
He holds a B.S. in Finance from the University of Southern California and a Certificate of Global CEO program from Yeonsei University.
was also accountable for overall team leadership and financial management, including overseeing credit portfolios and client deposit relationships for the past 26 years. He holds a B.S. in Finance from the University of Southern California and a Certificate of Global CEO program from Yeonsei University.
A 35+ year veteran in medical device development, Dan Tylutki, holds a Master of Science in Electrical Engineering from Santa Clara University, and a Bachelor of Science in Electrical Engineering from the University of Idaho.
He was responsible for product development management, project management, medical device quality systems, and regulatory affairs for various industry leaders, including Varian Medical Systems, Wavtrace, Mindplay, Northstar Neuroscience, and Light Sciences Oncology.
He brings his FDA class II/III medical device development to Cardiac Insight, with a mission to enhance the quality of life for patients and their families.
Amy Moon’s career is marked by a track record of excellence in senior sales and sales management. She has an extensive healthcare products and services background spanning more than two decades within the pharmaceutical and medical device sectors.
She demonstrated success in driving new business development, achieving revenue growth, and fostering strong customer relationships and service. Notably, her qualities include a commitment to exceeding sales goals, a keen eye for detail, and proficiency in addressing challenges.
She holds a B.A. in Journalism with a focus on Public Relations from Biola University.
Dr. Vic Froelicher, a Professor of Medicine and Sports Cardiology Consultant at Stanford Healthcare since 1992, has an impressive career in cardiology. His journey commenced at the USAF School of Aerospace Medicine, where he screened pilots, astronauts, and military athletes. With expertise in clinical exercise physiology, ECG interpretation, and screening, he co-authored the renowned textbook “Exercise and the Heart.”
His contributions are significant: Dr. Froelicher played a pivotal role in developing the first international document outlining ECG criteria to reduce false positives for sudden cardiac death in athletes. Additionally, he co-authored a chapter in the Olympic Committee’s 2017 Cardiology Manual.
With a remarkable academic journey, Dr. Robert Hauser earned his B.S. from The University of Cincinnati in 1961 and an M.D. from Cincinnati College of Medicine in 1968. Our founder received prestigious awards throughout his career, including the Chicago Heart Association Outstanding Achievement Award in 1987, the Michel Mirowski Award in 1996, and the Champions of Cardiology from the American College of Cardiology (Minnesota) in 2006.
His contributions were also recognized by the European Cardiac Arrhythmias Society in 2008, and he was granted the Shotwell Award in 2014. Having held positions as a Professor, Associate Professor, Assistant Professor, and Instructor in Medicine at Rush Medical College, Chicago,
Dr. Robert Hauser also served as Senior Consulting Cardiologist at Minneapolis Heart Institute, Minnesota, until his retirement in 2016.
After earning a B.S. in Biochemistry from UCLA in 2000, James pursued a Pharm.D. degree from the prestigious University of the Pacific School of Pharmacy, graduating in 2003. The early years of James Pai’s career were marked by valuable experience at both Sav-on Pharmacy and Costco Pharmacy from 2003 to 2011.
In 2007, the entrepreneurial spirit and a commitment to exceptional patient service made James Pai establish independent pharmacies, demonstrating a remarkable blend of business acumen and pharmaceutical expertise.